Literature DB >> 16328437

Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population.

Jing Jiang1, Jingweng Wang, Sadao Suzuki, Vendhan Gajalakshmi, Kiyonori Kuriki, Yang Zhao, Seiichi Nakamura, Susumu Akasaka, Hideki Ishikawa, Shinkan Tokudome.   

Abstract

PURPOSE: To investigate whether the common cyclin D1 (CCND1) A870G polymorphism is a risk factor for colorectal cancer (CRC) in an Indian population.
METHODS: In this study, 301 newly diagnosed CRC patients and 291 healthy control subjects were genotyped by the PCR-RFLP method. Genotype frequencies were compared between cases and controls, and the association of genotypes with CRC was studied.
RESULTS: The CCND1 870 A allele was more frequently observed in CRC patients than controls (0.63 vs. 0.56, P=0.01), and after adjustment for age, sex, smoking habits, family history, family income and the consumption of meat, fish, vegetables and fruit, an increased risk was observed for the AA genotype compared to the GG+AG genotype (OR=1.56; 95% CI: 1.10-2.21). The increased risk were also found for colon (OR=1.96; 95% CI: 1.08-3.57) and rectal cancer (OR=1.51; 95% CI: 1.04-2.19). No correlation was observed between genotypes and age of diagnosis of CRC (49.9, 48.7 and 49.4 years for the GG, AG and AA genotypes, respectively; P=0.84). Multivariate analysis also revealed a stronger positive association with the AA genotype among patients with high meat intake (OR=2.67; 95% CI: 1.29-5.51), and particularly significant inverse associations with the GG+AG genotypes were also found for those with high vegetable consumption (OR=0.46; 95% CI: 0.27-0.79 of 2-3 servings/day, and OR=0.31; 95% CI: 0.18-0.53 for >3 servings/day) and fish intake (OR=0.48; 95% CI: 0.28-0.82).
CONCLUSION: These data support the hypothesis that the CCND1 A870G polymorphism may increase the risk of CRC in our Indian population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328437     DOI: 10.1007/s00432-005-0039-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma.

Authors:  Chunyuan Yu; Wenfu Lu; Wen Tan; Deyin Xing; Gang Liang; Xiaoping Miao; Dongxin Lin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-02       Impact factor: 4.254

2.  Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer.

Authors:  S Kong; C I Amos; R Luthra; P M Lynch; B Levin; M L Frazier
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

3.  CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer.

Authors:  S Bala; P Peltomäki
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

4.  Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

Authors:  Lizhong Wang; Tomonori Habuchi; Takeshi Takahashi; Kenji Mitsumori; Toshiyuki Kamoto; Yoshiyuki Kakehi; Hideaki Kakinuma; Kazunari Sato; Akira Nakamura; Osamu Ogawa; Tetsuro Kato
Journal:  Carcinogenesis       Date:  2002-02       Impact factor: 4.944

5.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.

Authors:  T C Wang; R D Cardiff; L Zukerberg; E Lees; A Arnold; E V Schmidt
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

6.  Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.

Authors:  Fabienne Grieu; Suzann Malaney; Robyn Ward; David Joseph; Barry Iacopetta
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

7.  Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.

Authors:  M D Crabtree; C Fletcher; M Churchman; S V Hodgson; K Neale; R K S Phillips; I P M Tomlinson
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

8.  Overexpression of cyclin D1 enhances gene amplification.

Authors:  P Zhou; W Jiang; C M Weghorst; I B Weinstein
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

9.  Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.

Authors:  N Arber; H Hibshoosh; S F Moss; T Sutter; Y Zhang; M Begg; S Wang; I B Weinstein; P R Holt
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

10.  Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients.

Authors:  Abeer A Bahnassy; Abdel-Rahman N Zekri; Soumaya El-Houssini; Amal M R El-Shehaby; Moustafa Raafat Mahmoud; Samira Abdallah; Mostafa El-Serafi
Journal:  BMC Gastroenterol       Date:  2004-09-23       Impact factor: 3.067

View more
  14 in total

1.  Polymorphisms of cell cycle regulator genes CCND1 G870A and TP53 C215G: Association with colorectal cancer susceptibility risk in a Malaysian population.

Authors:  Mohd Nizam Zahary; Abdul Aziz Ahmad Aizat; Gurjeet Kaur; Lee Yeong Yeh; Maya Mazuwin; Ravindran Ankathil
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

2.  Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population.

Authors:  Jingwen Wang; Yang Zhao; Jing Jiang; Vendhan Gajalakshmi; Kiyonori Kuriki; Seiichi Nakamura; Susumu Akasaka; Hideki Ishikawa; Sadao Suzuki; Teruo Nagaya; Shinkan Tokudome
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-15       Impact factor: 4.553

3.  The significant association of CCND1 genotypes with colorectal cancer in Taiwan.

Authors:  Chung-Yu Huang; Chia-Wen Tsai; Chin-Mu Hsu; Wen-Shin Chang; Hao-Ai Shui; Da-Tian Bau
Journal:  Tumour Biol       Date:  2015-03-26

4.  Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.

Authors:  Lou-Qian Zhang; Jun Wang; Jun-Qing Shang; Jian-Ling Bai; Fu-Yin Liu; Xin Guan; Jian-Nong Zhou
Journal:  Int J Colorectal Dis       Date:  2011-05-05       Impact factor: 2.571

5.  The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.

Authors:  Changxi Zhou; Huaijie An; Mingdong Hu; Qinghui Liu; Peiliang Geng; Jiancheng Xu; Baojun Sun; Changting Liu
Journal:  Tumour Biol       Date:  2013-07-20

6.  Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes.

Authors:  Frank Grünhage; Matthias Jungck; Christoph Lamberti; Christine Berg; Ursula Becker; Hildegard Schulte-Witte; Dominik Plassmann; Nils Rahner; Stefan Aretz; Nicolaus Friedrichs; Reinhard Buettner; Tilman Sauerbruch; Frank Lammert
Journal:  Int J Colorectal Dis       Date:  2007-10-25       Impact factor: 2.571

7.  Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.

Authors:  Nora Manoukian Forones; Jacqueline Miranda de Lima; Lessileia Gomes de Souza; Ismael Dale Cotrim Guerreiro da Silva
Journal:  J Gastrointest Cancer       Date:  2009-04-17

8.  CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.

Authors:  Xiao-Ming Xu; Xiao-Bing Ni; Gong-Li Yang; Zhi-Guo Luo; Yu-Ming Niu; Ming Shen
Journal:  Mol Clin Oncol       Date:  2016-04-04

Review 9.  Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.

Authors:  Yongzhi Yang; Feng Wang; Chenzhang Shi; Yang Zou; Huanlong Qin; Yanlei Ma
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

10.  Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a meta-analysis.

Authors:  Meng Li; Weijian Dai; Huanqin Zhou
Journal:  ScientificWorldJournal       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.